DRD5 anticorps (N-Term)
-
- Antigène Voir toutes DRD5 Anticorps
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Épitope
- AA 19-56, N-Term
-
Reactivité
- Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DRD5 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogène
- This Drd5 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 19-56 amino acids from the N-terminal region of human Drd5.
- Clone
- RB52770
- Isotype
- Ig Fraction
- Top Product
- Discover our top product DRD5 Anticorps primaire
-
-
- Indications d'application
- WB: 1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Date de péremption
- 6 months
-
- Antigène
- DRD5 (Dopamine Receptor D5 (DRD5))
- Autre désignation
- Drd5 (DRD5 Produits)
- Synonymes
- anticorps DRD5, anticorps DBDR, anticorps DRD1B, anticorps DRD1L2, anticorps D1B, anticorps D5R, anticorps Drd-5, anticorps Drd1b, anticorps Gpcr1, anticorps dopamine receptor D5, anticorps DRD5, anticorps Drd5
- Sujet
- Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
- Poids moléculaire
- 53076
- UniProt
- Q8BLD9
- Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
-